Diabetes mellitus induces decreased plasma fibrinolytic activity and increased tissue synthesis of plasminogen activator inhibitor-1 (PAI-1) in the rat

被引:5
作者
Pandolfi, A
Giaccari, A
Polishuck, R
Alberta, MM
Pellegrini, G
Morviducci, L
Vitacolonna, E
Buongiorno, AM
Capani, F
Consoli, A
机构
[1] Univ G dAnnunzio, Dipartimento Med & Sci Invecchiamento, Chieti, Italy
[2] Univ Cattolica Sacro Cuore, Ist Endocrinol, Rome, Italy
[3] Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy
[4] Ist Super Sanita, Reparto Immunometria, I-00161 Rome, Italy
来源
FIBRINOLYSIS & PROTEOLYSIS | 2000年 / 14卷 / 04期
关键词
D O I
10.1054/fipr.2000.0083
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In diabetes, plasma fibrinolytic activity is decreased while plasma plasminogen activator inhibitor-1 (PAI-1) is increased. Both liver and adipose tissue can synthesize and release PAI-1, but PAI-1 synthesis in these tissues has not been investigated in diabetes. Furthermore, little is known about PAI-1 localization in arterial wall cells of diabetic animals. The aim of this study was to determine the effect of chronic hyperglycemia on plasma fibrinolysis and plasma PAI-1 levels and on liver, adipose tissue and arterial wall PAI-1 content in the rat. We compared plasma fibrinolytic activity (lysis of fibrin plates) and plasma PAI-1 activity (chromogenic assay) in 10 Sprague Dowley 90% pancreatectomized rats (a model of diabetes characterized by normal fasting insulin and the absence of obesity, therefore closely resembling lean type 2 diabetes) and in 15 sham-operated rats. Furthermore, we measured PAI-1-related fluorescence, by immunofluorescent staining and Laser Scanning Confocal Microscopy, in liver, adipose tissue and aortic wall in diabetic and control animals. In the diabetic animals plasma fibrinolytic activity was reduced (lysis areas = 163 +/- 23 vs 308 +/- 21 mm(2), P < 0.001), while plasma PAI-1 activity was increased (4.61 +/- 2.01 AU vs 0.70 +/- 0.59 AU, P < 0.02). PAI-1 related fluorescence was increased in the liver (754 +/- 25 vs 299 +/- 14 AFU, P < 0.0001), in the adipose tissue (721 +/- 32 vs 248 +/- 14 AFU, P < 0.001) and in the aorta wall (339 +/- 18 vs 274 +/- 9 AFU, P < 0.005) of the diabetic animals. These data provide evidence that in diabetes mellitus hyperglycemia is associated with increased PAI-1 content in the liver, adipose tissue and in the arterial wall. This suggests that in diabetes the liver and adipose tissue can be important sources for increased plasma PAI-1 and local fibrinolysis can be affected by increased PAI-1 levels in the arterial wall. (C) 2000 Harcourt Publishers Ltd.
引用
收藏
页码:261 / 267
页数:7
相关论文
共 38 条
[1]   Production of plasminogen activator inhibitor 1 by human adipose tissue - Possible link between visceral fat accumulation and vascular disease [J].
Alessi, MC ;
Peiretti, F ;
Morange, P ;
Henry, M ;
Nalbone, G ;
JuhanVague, I .
DIABETES, 1997, 46 (05) :860-867
[2]   TISSUE-TYPE PLASMINOGEN-ACTIVATOR ANTIGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR IN DIABETES-MELLITUS [J].
AUWERX, J ;
BOUILLON, R ;
COLLEN, D ;
GEBOERS, J .
ARTERIOSCLEROSIS, 1988, 8 (01) :68-72
[3]   PARTIAL PANCREATECTOMY IN THE RAT AND SUBSEQUENT DEFECT IN GLUCOSE-INDUCED INSULIN RELEASE [J].
BONNERWEIR, S ;
TRENT, DF ;
WEIR, GC .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (06) :1544-1553
[4]   Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects [J].
Calles-Escandon, J ;
Mirza, SA ;
Sobel, BE ;
Schneider, DJ .
DIABETES, 1998, 47 (02) :290-293
[5]   Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells [J].
Chen, YQ ;
Su, M ;
Walia, RR ;
Hao, Q ;
Covington, JW ;
Vaughan, DE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (14) :8225-8231
[6]  
Davi G, 1996, THROMB HAEMOSTASIS, V76, P34
[7]   Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals [J].
Eriksson, P ;
Reynisdottir, S ;
Lönnqvist, F ;
Stemme, V ;
Hamsten, A ;
Arner, P .
DIABETOLOGIA, 1998, 41 (01) :65-71
[8]  
Foglia Virgilio G., 1944, REV SOC ARGENTINA BIOL, V20, P21
[9]   HYPOFIBRINOLYSIS ASSOCIATED WITH VASCULOPATHY IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
FRADE, LJG ;
DELACALLE, H ;
TORRADO, MC ;
LARA, JI ;
CUELLAR, L ;
AVELLO, AG .
THROMBOSIS RESEARCH, 1990, 59 (01) :51-59
[10]   IN-VIVO EFFECTS OF GLUCOSAMINE ON INSULIN-SECRETION AND INSULIN SENSITIVITY IN THE RAT - POSSIBLE RELEVANCE TO THE MALADAPTIVE RESPONSES TO CHRONIC HYPERGLYCEMIA [J].
GIACCARI, A ;
MORVIDUCCI, L ;
ZORRETTA, D ;
SBRACCIA, P ;
LEONETTI, F ;
CAIOLA, S ;
BUONGIORNO, A ;
BONADONNA, RC ;
TAMBURRANO, G .
DIABETOLOGIA, 1995, 38 (05) :518-524